Home › Funds › CIBC Bancorp USA Inc. › ABT

CIBC Bancorp USA Inc. position in ABT

ABBOTT LABORATORIES · Health Care

CIBC Bancorp USA Inc. reported holding 3,526,325 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$349.1M, representing 0.50% of its reported portfolio and ranking #38 among its reported holdings. CIBC Bancorp USA Inc. has disclosed ABT holdings in 4 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)3.53M sh
Reported value held$349.08M
Portfolio Weight0.50%
First reportedQ3 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CIBC Bancorp USA Inc.'s ABT position evolved

CIBC Bancorp USA Inc. first disclosed a stake in ABT in Q3 2025 at 254,905 shares (US$34.1M). The position peaked in Q1 2026 at 4,211,858 shares, worth US$432.5M. Across 4 filings, CIBC Bancorp USA Inc. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,526,325 shares valued at US$349.1M — a reduction of -364,434 shares quarter over quarter.. Notable position changes include a 1552% increase in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 254.91K $34.14M New
Q1 2026 4.21M $432.52M Add
Q2 2026 3.89M $353.23M Reduce
Q3 2026 3.53M $349.08M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has CIBC Bancorp USA Inc. held ABT?

CIBC Bancorp USA Inc. has disclosed ABT holdings in 4 of the last 5 reported quarters, going back to Q3 2025.

What is CIBC Bancorp USA Inc.'s current position in ABT?

As of Q3 2026, CIBC Bancorp USA Inc. holds 3.53M shares of ABT (ABBOTT LABORATORIES), valued at $349.08M, representing 0.50% of its reported portfolio and ranking #38.

Has CIBC Bancorp USA Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), CIBC Bancorp USA Inc. reduced its position in ABT. The position peaked in Q1 2026 at 4.21M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.